The application of biomarkers for 'recent' infection in cross-sectional HIV incidence surveillance requires the estimation of critical biomarker characteristics. Various approaches have been employed for using longitudinal data to estimate the Mean Duration of Recent Infection (MDRI) - the average time in the 'recent' state. In this systematic benchmarking of MDRI estimation approaches, a simulation platform was used to measure accuracy and precision of over twenty approaches, in thirty scenarios capturing various study designs, subject behaviors and test dynamics that may be encountered in practice. Results highlight that assuming a single continuous sojourn in the 'recent' state can produce substantial bias. Simple interpolation provides ...
ObjectiveTo determine the precision of new and established methods for estimating duration of HIV in...
In studies of the natural history of HIV-1 infection, the time scale of primary interest is the time...
ObjectiveAssays for classifying HIV infections as 'recent' or 'nonrecent' for incidence surveillance...
The application of biomarkers for ‘recent’ infection in cross-sectional HIV incidence surveillance r...
Accurate estimates of incidence rates of infectious diseases are important for monitoring trends and...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Tracking and surveillance of the HIV epidemic depend on accurate estimation of the number of new inf...
Estimation of an HIV incidence rate based on a cross-sectional sample of individuals evaluated with ...
In longitudinal studies of biomarkers, an outcome of interest is the time at which a biomarker reach...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
Cross-sectional HIV incidence estimation based on a sensitive and less-sensitive test offers great a...
Estimating the time since HIV infection (TSI) at population level is essential for tracking changes ...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
The incidence of human immunodeficiency virus (HIV) is the rate at which new HIV infections occur in...
ObjectiveTo determine the precision of new and established methods for estimating duration of HIV in...
In studies of the natural history of HIV-1 infection, the time scale of primary interest is the time...
ObjectiveAssays for classifying HIV infections as 'recent' or 'nonrecent' for incidence surveillance...
The application of biomarkers for ‘recent’ infection in cross-sectional HIV incidence surveillance r...
Accurate estimates of incidence rates of infectious diseases are important for monitoring trends and...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as pro...
Tracking and surveillance of the HIV epidemic depend on accurate estimation of the number of new inf...
Estimation of an HIV incidence rate based on a cross-sectional sample of individuals evaluated with ...
In longitudinal studies of biomarkers, an outcome of interest is the time at which a biomarker reach...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
Cross-sectional HIV incidence estimation based on a sensitive and less-sensitive test offers great a...
Estimating the time since HIV infection (TSI) at population level is essential for tracking changes ...
Tests for recent infections (TRIs) are important for HIV surveillance. We have shown that a patient'...
The incidence of human immunodeficiency virus (HIV) is the rate at which new HIV infections occur in...
ObjectiveTo determine the precision of new and established methods for estimating duration of HIV in...
In studies of the natural history of HIV-1 infection, the time scale of primary interest is the time...
ObjectiveAssays for classifying HIV infections as 'recent' or 'nonrecent' for incidence surveillance...